91九色视频

header-logo
GettyImages-609179959-hero
headshot

Sameem Abedin, MD

Associate Professor

view physician profile

Locations

  • Froedtert Hospital
  • Cancer Center - Froedtert Hospital

Specialties

  • Hematology
  • Medical Oncology

Languages

  • English, Bengali

Cancer Center - Froedtert Hospital

Education

  • MD - Doctor of Medicine

Biography

Sameem Abedin, MD, is an associate professor of medicine (hematology and oncology) at the 91九色视频. His specialization is in leukemia and stem cell transplantation at Froedtert Hospital. He obtained his undergraduate degree at the University of Pennsylvania, PA, in 2004, and his medical degree at Jefferson Medical College in 2009. He completed his residency in Internal Medicine at the University of Pittsburgh Medical Center in Pittsburgh, PA, in 2012. In 2017, he then completed his fellowship in Hematology and Oncology at Northwestern University in Chicago, IL, where he also served as Chief Fellow. His current clinical and research interests include patients with acute leukemia, including AML and ALL, myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPNs), chronic myeloid leukemia (CML), and allogeneic stem cell transplantation for these conditions. His professional memberships include the American Society of Hematology and the American Society of Bone Marrow Transplantation.

Dr. Abedin is board certified by the American Board of Internal Medicine (ABIM) in Internal Medicine, and in Hematology and Medical Oncology.

Publications

  • (Davids MS, Brander DM, Alvarado-Valero Y, Diefenbach CS, Egan DN, Dinner SN, Javidi-Sharifi N, Al Malki MM, Begna KH, Bhatt VR, Abedin S, Cook RJ, Collins MC, Roleder C, Dominguez EC, Rajagopalan P, Wiley SE, Ghalie RG, Danilov AV.) Blood Adv. 2025 Feb 25;9(4):820-832 PMID: 39705540 PMCID: PMC11872473 SCOPUS ID: 2-s2.0-85218726366 12/20/2024

  • (Abedin SM, Guru Murthy GS, Hamadani M, Michaelis LC, Carlson KS, Runaas L, Gauger K, Desai AG, Chen MM, Li KL, Rotibi M, Syed U, Vusirikala M, Harrington A, Atallah EL.) Leukemia. 2025 Feb 15 PMID: 39955432 SCOPUS ID: 2-s2.0-85218187693 02/16/2025

  • (Abedin SM, Uy GL, Michaelis LC.) Blood. 2025 Jan 24 PMID: 39854694 SCOPUS ID: 2-s2.0-85218861926 01/24/2025

  • (Abedin S, Hamadani M.) Curr Hematol Malig Rep. 2024 Dec;19(6):246-255 PMID: 39520614 SCOPUS ID: 2-s2.0-85208814138 11/13/2024

  • (Murthy GSG, Saliba AN, Szabo A, Harrington A, Abedin S, Carlson K, Michaelis L, Runaas L, Baim A, Hinman A, Maldonado-Schmidt S, Venkatachalam A, Flatten KS, Peterson KL, Schneider PA, Litzow M, Kaufmann SH, Atallah E.) Haematologica. 2024 Sep 01;109(9):2864-2872 PMID: 38572562 PMCID: PMC11367232 SCOPUS ID: 2-s2.0-85201433013 04/04/2024

  • (Furqan F, Bhatlapenumarthi V, Dhakal B, Fenske TS, Farrukh F, Longo W, Akhtar O, D'Souza A, Pasquini M, Guru Murthy GS, Runaas L, Abedin S, Mohan M, Shah NN, Hamadani M.) Blood Adv. 2024 Aug 27;8(16):4320-4329 PMID: 38889435 PMCID: PMC11372811 SCOPUS ID: 2-s2.0-85203009004 06/18/2024

  • (Kim NH, Hamadani M, Abedin S.) Expert Opin Investig Drugs. 2024 Aug;33(8):791-799 PMID: 38973782 PMCID: PMC11305901 SCOPUS ID: 2-s2.0-85198098956 07/08/2024

  • (Chhabra S, Jerkins JH, Monahan K, Szabo A, Shah NN, Abedin S, Runaas L, Fenske TS, Pasquini MC, Shaw BE, Drobyski WR, Saber W, D'Souza A, Dhakal B, Mohan M, Longo W, Hamadani M.) Bone Marrow Transplant. 2024 Mar;59(3):373-379 PMID: 38177221 SCOPUS ID: 2-s2.0-85181508004 01/05/2024

  • (Abid MB, Rubin M, Szabo A, Longo W, Fenske TS, McCoy C, Lorge A, Abedin S, D'Souza A, Dhakal B, Shah NN, Hamadani M.) Transplant Cell Ther. 2024 Mar;30(3):285-297 PMID: 38142942 SCOPUS ID: 2-s2.0-85183537164 12/25/2023

  • (Watts J, Minden MD, Bachiashvili K, Brunner AM, Abedin S, Crossman T, Zajac M, Moroz V, Egger JL, Tarkar A, Kremer BE, Barbash O, Borthakur G.) Ther Adv Hematol. 2024;15:20406207241275376 PMID: 39290981 PMCID: PMC11406655 SCOPUS ID: 2-s2.0-85204294507 09/18/2024

  • (Jain T, Tsai HL, Elmariah H, Vachhani P, Karantanos T, Wall SA, Gondek LP, Bashey A, Keyzner A, Tamari R, Grunwald MR, Abedin S, Nadiminti KV, Iqbal M, Gerds AT, Viswabandya A, McCurdy SR, Al Malki MM, Varadhan R, Ali H, Gupta V, Jones RJ, Otoukesh S.) Haematologica. 2023 Dec 01;108(12):3321-3332 PMID: 37408464 PMCID: PMC10690921 SCOPUS ID: 2-s2.0-85167782436 07/06/2023

  • (Taylor S, Murthy GSG, Runaas L, Michaelis LC, Carlson K, Atallah EL, Abedin SM.) Leuk Res. 2023 Sep;132:107348 PMID: 37423073 SCOPUS ID: 2-s2.0-85164434355 07/10/2023

Publications of from the

© 2025 91九色视频.  All rights reserved.  | Terms and Privacy | Web Accessibility Statement

Non-Discrimination Statement
The 91九色视频 (91九色视频) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, or military status. Employees, students, applicants or other members of the 91九色视频 community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic. 91九色视频’s policy as well as federal and state laws and regulations prohibit unlawful discrimination and harassment.

Notice of Compliance with Laws and Commitment to Civil Rights
The 91九色视频 is committed to full compliance with all applicable federal, state, and local laws and regulations in the pursuit of our missions. Consistent with recent federal guidance, we affirm our commitment to individual merit, fairness, and equal treatment in all aspects of academic and institutional decision-making. As part of this commitment, we are actively reviewing our policies and materials to ensure they align with federal nondiscrimination obligations.